Evidence map›Paper›PMID 28973161›Full record

ArticleHuman molecular genetics2017

Identification of a novel synaptic protein, TMTC3, involved in periventricular nodular heterotopia with intellectual disability and epilepsy.

Sali M K Farhan, Kevin C J Nixon, Michelle Everest, Tara N Edwards, Shirley Long, Dmitri Segal, Maria J Knip, Heleen H Arts, Rana Chakrabarti, Jian Wang and 9 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Prognostic value ofHeliyon · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. The SHDRA syndrome-associated geneProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Novel compound variants of theExperimental and therapeutic medicine · 2020
    Article
  16. Investigating Developmental and Epileptic Encephalopathy UsingInternational journal of molecular sciences · 2020
    Review
  17. Article
  18. Article
  19. Review
  20. A Report on a Family withCase reports in medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

Sali M K FarhanMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
Kevin C J NixonDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
Michelle EverestMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
Tara N EdwardsDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
Shirley LongDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
Dmitri SegalDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
Maria J KnipDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
Heleen H ArtsMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
Rana ChakrabartiDivision of Genetics and Development, Children's Health Research Institute, London, ON, Canada, N6A 5W9.
Jian WangMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
John F RobinsonMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
Donald LeeDepartment of Medical Imaging.
Seyed M MirsattariDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
C Anthony RuparDepartment of Biochemistry.
Victoria M SiuDepartment of Biochemistry.
FORGE Canada Consortium
Michael O PoulterMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
Robert A HegeleMolecular Medicine Research Group, Robarts Research Institute, London, ON, Canada, N6A 5B7.
Jamie M KramerDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada, N6A 5C1.
Western University · CARobarts Clinical Trials · CAChildren’s Health Research Institute · CA

Funding

CIHR
6 · The paper itself

Abstract

Defects in neuronal migration cause brain malformations, which are associated with intellectual disability (ID) and epilepsy. Using exome sequencing, we identified compound heterozygous variants (p.Arg71His and p. Leu729ThrfsTer6) in TMTC3, encoding transmembrane and tetratricopeptide repeat containing 3, in four siblings with nocturnal seizures and ID. Three of the four siblings have periventricular nodular heterotopia (PVNH), a common brain malformation caused by failure of neurons to migrate from the ventricular zone to the cortex. Expression analysis using patient-derived cells confirmed reduced TMTC3 transcript levels and loss of the TMTC3 protein compared to parental and control cells. As TMTC3 function is currently unexplored in the brain, we gathered support for a neurobiological role for TMTC3 by generating flies with post-mitotic neuron-specific knockdown of the highly conserved Drosophila melanogaster TMTC3 ortholog, CG4050/tmtc3. Neuron-specific knockdown of tmtc3 in flies resulted in increased susceptibility to induced seizures. Importantly, this phenotype was rescued by neuron-specific expression of human TMTC3, suggesting a role for TMTC3 in seizure biology. In addition, we observed co-localization of TMTC3 in the rat brain with vesicular GABA transporter (VGAT), a presynaptic marker for inhibitory synapses. TMTC3 is localized at VGAT positive pre-synaptic terminals and boutons in the rat hypothalamus and piriform cortex, suggesting a role for TMTC3 in the regulation of GABAergic inhibitory synapses. TMTC3 did not co-localize with Vglut2, a presynaptic marker for excitatory neurons. Our data identified TMTC3 as a synaptic protein that is involved in PVNH with ID and epilepsy, in addition to its previously described association with cobblestone lissencephaly.

Indexed as

AdultAnimalsBrainCarrier ProteinsCerebral CortexDrosophila melanogasterEpilepsyExome SequencingFemaleGene Knockdown TechniquesHeterozygoteHumansIntellectual DisabilityMaleMembrane ProteinsNervous System MalformationsCarrier ProteinsMembrane ProteinsTMTC3 protein, human

Identifiers

PMID28973161
PMCPMC5886076
OpenAlexW2765091165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.